Synpromics: Lonza chooses Synpromics' novel inducible promoter platform to manufacture biopharmaceuticals
Lonza and Synpromics worked together to develop and test these innovative promoters in Lonza's industry-leading GS Xceed® Expression System.
Read full article »
CEO
Synpromics is a biotechnology company that provides synthetic bioinformatics platform for developing gene medicines.
Read more